Was 3.692%, improvement adequate at Conifer Holdings Inc in the financial period closing Dec 31 2022

For the fourth quarter of 2022 Conifer Holdings Inc had turn a round to income by posting EPS of $0.15 per share compare to $-0.08 a year ago and income per share turned positive from $-0.14 per share from the preceding reporting season.

Revenue increased modest by 3.692 % to $28.50 millions from $27.49 millions in the similar reporting season a year ago and sequentially Revenues advanced by 8.232 % from $26.34 millions.

Conifer Holdings Inc Customers

Conifer Holdings Inc improvement Rates, Profitability, PE

The emerging corporation from the Major Pharmaceutical Preparations sector the RPHM released the financial interval ending fourth quarter of 2022, results

The shareholders have not assumed some modifications at the revenue all over the earnings cycle of fiscal October to December 31 2022 season at the Reneo Pharmaceuticals Inc . But, stockholders observe the Major Pharmaceutical Preparations company's operating shortfall that was at $-14.562 millions, during the matching time.

Reneo Pharmaceuticals Inc Customers

Reneo Pharmaceuticals Inc Revenue growth Rates

In the fourth quarter of 2022 financial report company decreased a loss per share at $-0.98 per share, opposite of $-1.06 per share a year before financial reporting period, In the previous financial reporting period Impel Pharmaceuticals Inc realized $-1.31 per share.

Impel Pharmaceuticals Inc Competitors, Market Share

Impel Pharmaceuticals Inc growth Rates, Profitability, PE

Underlining the most recent fiscal period CTMX lost money at $-0.42 per share, relative to the earnings of $-0.91 per share a year ago quarter, In the prior quarter CTMX realized $-0.35 per share.

Cytomx Therapeutics Inc Competitors, Market Share

Cytomx Therapeutics Inc Revenue growth Rates

For the financial interval closing December 31 2022 Acer Therapeutics Inc increased a loss per share of $-0.54 per share compare to $-0.30 a year before and grew loss from $-0.31 per share from the previous quarter.

Revenues remained unaffected to $0.00 millions from $0.36 millions in the comparable quarter a year before and sequentially Revenue Tumbled from $0.00 millions.

Acer Therapeutics Inc stock quotes, charts, profile

Acer Therapeutics Inc Revenue advance Rates

A humbling fiscal period by Pennsylvania Real Estate Investment Trust all along the fourth quarter of 2022

For the financial fourth quarter of 2022 Pennsylvania Real Estate Investment Trust Losses have widen of $-7.81 per share compare to $-0.43 a year ago and earnings per share improved from $-14.52 per share from the previous financial reporting period.

Revenues depreciated by -5.307 % to $80.65 millions from $85.17 millions in the comparable financial reporting period a year ago and sequentially Revenues advanced by 10.767 % from $72.81 millions.

Pennsylvania Real Estate Investment Trust stock quotes, charts, profile

Pennsylvania Real Estate Investment Trust Suppliers

For the fiscal span closing December 31 2022 Terns Pharmaceuticals Inc decreased a loss per share of $-0.23 per share compare to $-0.56 a year before and EPS improved from $-0.44 per share from the previous quarter.

Revenues remained unscathed to $0.00 millions from $1.00 millions in the similar quarter a year before and sequentially Revenues advanced from $0.00 millions.

Terns Pharmaceuticals Inc stock quotes, charts, profile

Terns Pharmaceuticals Inc Suppliers

For the October to December 31 2022 interval GROY lost money of $-0.14 per share compare to $-0.14 a year before and from $0.00 per share from the previous quarter.

Revenues remained unscathed by 0 % to $3.94 millions from $3.94 millions in the corresponding quarter a year before and sequentially Revenues advanced from $0.00 millions.

Gold Royalty Corp stock quotes, charts, profile

Gold Royalty Corp Suppliers

Concentrating on the fourth quarter of 2022 earnings season P10 Inc profitability turned positive at $0.03 per share, relative to the earnings of $-3.47 per share a year prior reporting season, In the previous reporting season the Investment Services company realized $0.05 per share.

P10 Inc stock quotes, charts, profile

P10 Inc Suppliers